Pathological Conditions, Signs and Symptoms

144 trials 75 recruiting

Filter these 144 trials by phase, country and sponsor.

Open in Search →

BOOSTER – Multicenter, Open Label, Randomized Control Phase III Trial Comparing the Efficacy and Safety of Two Rituximab Regimens in Mainten… Recruiting

2023-509755-13-00 Idiopathic steroid-sensitive nephrotic syndrome 5 2025-04-28
A phase 2 clinical trial on neoadjuvant pembrolizumab in patients diagnosed with high-risk melanoma without clinical evidence of metastatic … Recruiting

2024-517840-68-00 Melanoma 4 2025-04-11
LYSARI – LYmphocyte-Sparing And Radio-Immunotherapy in Head and neck carcinoma - A multicenter, randomised 2*2 factorial design comparing st… Recruiting

2022-501315-13-00 Patients with lateralised oropharyngeal, laryngeal and 5 2025-03-06
Whole body HER3 quantification with radiolabelled Patritumab deruxtecan (HER3-DXd) PET/CT Recruiting

2023-508233-14-00 EGFR mutation positive advanced stage NSCLC 4 2025-03-03
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept Recruiting

2024-516380-81-00 Treatment of IgAN 4 2025-02-28
NEFARTHRO - Effets précoces et tardifs du néfopam dans l'analgésie multimodale après arthroplastie totale de hanche Recruiting

2023-504079-26-01 Arthroplastie totale de hanche 5 2025-02-10
PRESENT: Primary care dySpEpsia rikkuNshiTo Recruiting

2024-515756-20-00 Functional Dyspepsia 5 2025-01-30
Fast-Track Therapeutic Model in Complicated Acute Appendicitis Recruiting

2025-520777-39-00 Complicated acute appendicitis 6 2025-01-29
Prednisone treatment in acute interstitial nephritis (PRAISE) Recruiting

2024-520299-86-00 Acute interstitial nephritis 6 2025-01-22
DASSOH - Systematic use of DDAVP to prevent serum sodium overcorrection in severe hyponatremia : a multicenter open-label randomized control… Recruiting

2023-507254-32-00 Severe hyponatremia and a high risk of rapid SNa overco 5 2024-12-17
A Phase II Study with Sevuparin in Subjects with Chronic Kidney Disease Recruiting

2024-513864-24-00 Chronic kidney disease 4 2024-11-28
Use of statins in patients with intracerebral hemorrhage Recruiting

2024-511465-11-00 Spontaneous lobar ICH 5 2024-11-20
A phase IB clinical trial on neoadjuvant and intraoperative intracranial administration of triple immune checkpoint blockade plus myeloid d… Recruiting

2024-517842-33-01 glioblastoma 3 2024-11-20
Efficacy and safety of adjunctive IgM-enriched immunoglobulin therapy with a personalized dose based on serum IgM-titers vs. standard dose i… Recruiting

2024-518096-57-00 Septic shock 5 2024-11-11
A PHASE 2A, EXPLORATORY, TWO-PART, OPEN-LABLE TRIAL TO EVALUATE DOSE AND SAFETY OF NANOECHO PARTICLE-1 (FERUMOXTRAN) USING NANOECHO IMAGIN… Recruiting

2024-515335-29-00 Rectal cancer 4 2024-10-16
Beneficial effects of Amiloride on progression of Chronic Kidney Disease: A-CKA Recruiting

2022-500692-31-00 Chronic kidney disease (CKD) 4 2024-10-10
Kidney ABC Recruiting

2024-511484-29-00 Diabetic kidney disease 4 2024-10-09
Testing Exendin PET, a new imaging technique, for imaging paragangliomas Recruiting

2024-516755-40-00 paragangliomas 4 2024-09-27
Evaluation of the expression of somatostatin receptors in DOTATOC-68Ga PET scans in patients followed for metastatic breast cancer Recruiting

2023-504458-36-02 Breast Cancer 4 2024-09-26
Improved breast cancer therapy (I-BCT-1) in the neoadjuvant and metastatic setting: A phase 2 clinical trial protocol studying biological ra… Recruiting

2024-515087-31-00 Breast cancer 9 2024-09-10
ElucidatiNg Immunosuppressant pharmacokinetic variabilities by investigating Gut Microbiota modulations After kidney transplantation - ENIGM… Recruiting

2023-508335-31-00 Chronic renal failure 6 2024-09-02
A randomized trial of multi-factorial primary prevention in high risk subjects candidate to a lung cancer early detection CT program Recruiting

2024-513660-26-00 Subjects at high risk of inflammatory state and mortali 4 2024-08-06
The NIPA study: A randomized double-blind control clinical trial Naloxegol administration to prevent opioids induced gastrointestinal motili… Recruiting

2024-512004-19-01 Head trauma 5 2024-07-02
Study to evaluate the safety of MAQ-001 as monotherapy and combination therapy in patients with advanced cancers Recruiting

2023-507774-41-00 Advanced cancer histologies for which immune checkpoint 1 2024-05-29